Recombinant malaria vaccine - Lumen Bioscience
Alternative Names: Spirulina-based malaria vaccineLatest Information Update: 10 Jan 2023
At a glance
- Originator Lumen Bioscience; University of Washington
- Class Antimalarials; Malaria vaccines; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Malaria